S1 File - Utilization of psychotropic drugs in Serbia from 2006 to 2021: Patterns before and during the COVID-19 pandemic

S1A Fig: Linear regression analysis shows statistically insignificant changes in trends in the consumption of psychotropic drugs in the observed time period. No statistically significant changes in consumption were observed for haloperidol, lorazepam, nitrazepam, oxazepam, topiramate, and ziprasidone over the analyzed period. S1B Fig: Linear regression analysis shows statistically insignificant changes in trends in the consumption of psychotropic drugs in the observed time period. No statistically significant changes in consumption were observed for brotizolam, carbamazepine, lithium carbonate, sulpiride, valproate, vinpocetine, zuclopenhixol, fluoxetine, clomipraimne. over the analyzed period. S2A Fig: Joinpoint regression analysis shows statistically insignificant changes in trends in the consumption of other psychotropic drugs in the observed time period, except for topiramate (antiepileptics) where it shows a statistically significant decrease. No statistically significant changes in consumption were observed for haloperidol, lorazepam, nitrazepam, oxazepam, and ziprasidone over the analyzed period. S2B Fig: Joinpoint regression analysis shows statistically insignificant changes in trends in the consumption of other psychotropic drugs in the observed time period, except for sulpiride (antipsychotic) where it shows a statistically significant increase. No statistically significant changes in consumption were observed for brotizolam, carbamazepine, lithium carbonate, valproate, vinpocetine, zuclopenhixol, fluoxetine, clomipraimne over the analyzed period.
(7Z)